Good afternoon :)
Switch to
Place Order

How to use scorecard? Learn more

Dr. Lal PathLabs Ltd

LALPATHLAB
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹15,871 cr, stock is ranked 257
Moderate RiskStock is 2.36x as volatile as Nifty
1,960.452.38% (+45.55)
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹15,871 cr, stock is ranked 257
Moderate RiskStock is 2.36x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
48.5910.850.60%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
33.634.120.94%

Forecast & RatingsDetailed Forecast 

25%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Investor PresentationView older 

Nov 8, 2022

PDF
View Older Presentations

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+1.25+1.39+1.63+2.14+0.20+0.23+0.29+0.34
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnFeb 7, 2023

Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet | Download

Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnFeb 6, 2023

Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet | Download

Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet | Download

Cash Dividend 
Ex. DateAug 5, 2022

Interim • Div/Share: ₹ 6

See all events